Generic comorbidity measures developed to predict mortality and/or healthcare costs are often used as adjustment covariates in observational studies comparing health expenditures between different therapeutic strategies. The objective of this review is to identify available measures, and assess their performance for prediction of economic outcomes using large longitudinal patient databases.